Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 18573039)

Published in Microb Drug Resist on June 01, 2008

Authors

João Perdigão1, Rita Macedo, Inês João, Elisabete Fernandes, Laura Brum, Isabel Portugal

Author Affiliations

1: Centro de Patogénese Molecular, URIA, Faculdade de Farmácia da Universidade de Lisboa, Lisbon, Portugal.

Articles citing this

Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PLoS One (2012) 1.46

Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2012) 1.13

Combined species identification, genotyping, and drug resistance detection of Mycobacterium tuberculosis cultures by MLPA on a bead-based array. PLoS One (2012) 1.12

A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis. PLoS One (2015) 0.99

Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting. BMC Genomics (2014) 0.88

Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland. PLoS One (2014) 0.87

Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria. Clin Microbiol Rev (2016) 0.84

Molecular epidemiology and clinical characteristics of drug-resistant Mycobacterium tuberculosis in a tuberculosis referral hospital in China. PLoS One (2014) 0.78

Genotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012. BMC Microbiol (2016) 0.75

Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. BMC Infect Dis (2016) 0.75

Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis. PLoS One (2015) 0.75

Insights into Pyrazinamidase and DNA Gyrase Protein Structures in Resistant and Susceptible Clinical Isolates of Mycobacterium tuberculosis. Tanaffos (2016) 0.75

Articles by these authors

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J (2013) 2.80

Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PLoS One (2012) 1.46

Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2002) 1.30

pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates in Portugal. Antimicrob Agents Chemother (2004) 1.17

Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. J Antimicrob Chemother (2009) 1.01

High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations. J Antimicrob Chemother (2013) 1.00

Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations. Int J Antimicrob Agents (2008) 0.94

Non-tuberculous mycobacteria in HIV-negative patients with pulmonary disease in Lisbon, Portugal. Scand J Infect Dis (2010) 0.94

Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours. Mol Oncol (2013) 0.93

Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis. Nanotechnology (2010) 0.92

Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections. Expert Rev Anti Infect Ther (2010) 0.89

Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting. BMC Genomics (2014) 0.88

From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition. J Antimicrob Chemother (2012) 0.87

A rapid and simple method for identifying Mycobacterium tuberculosis W-Beijing strains based on detection of a unique mutation in Rv0927c by PCR-SSCP. Microbes Infect (2009) 0.84

[Laboratory surveillance of drug resistance tuberculosis in Portugal in 2000-2001]. Rev Port Pneumol (2009) 0.81

SNP typing reveals similarity in Mycobacterium tuberculosis genetic diversity between Portugal and Northeast Brazil. Infect Genet Evol (2013) 0.80

Molecular epidemiology of Mycobacterium tuberculosis in Lisbon. Rev Port Pneumol (2008) 0.80

Pre-multidrug-resistant Mycobacterium tuberculosis Beijing strain associated with disseminated tuberculosis in a pet dog. J Clin Microbiol (2013) 0.79

Genotypic analysis of Mycobacterium tuberculosis isolates from a Lisbon hospital in Portugal. Rev Port Pneumol (2009) 0.79

Exploring the contribution of mycobacteria characteristics in their interaction with human macrophages. Microsc Microanal (2013) 0.75

Multidrug-Resistant Mycobacterium tuberculosis of the Latin American Mediterranean Lineage, Wrongly Identified as Mycobacterium pinnipedii (Spoligotype International Type 863 [SIT863]), Causing Active Tuberculosis in South Brazil. J Clin Microbiol (2015) 0.75

Endopolysaccharides from Ganoderma resinaceum, Phlebia rufa, and Trametes versicolor affect differently the proliferation rate of HepG2 cells. Appl Biochem Biotechnol (2013) 0.75

Clinical characteristics of patients with lung cancer and metachronous or synchronous tumours with other locations. Rev Port Pneumol (2010) 0.75

Fragment-Based De Novo Design of Antimycobacterial Agents and In Vitro Potency Evaluation. Comb Chem High Throughput Screen (2016) 0.75

Improving influenza surveillance in Portuguese preschool children by parents' report. Eur J Pediatr (2014) 0.75